Who is sponsoring NCT04331652?

NCT04331652 is sponsored by Hopital Foch.

What drugs are being tested in NCT04331652?

Interventions in NCT04331652: Polypectomy without anesthesia or analgo-sedation.

What condition does NCT04331652 study?

NCT04331652 studies Polyps Uterus.

Is NCT04331652 still recruiting?

NCT04331652 is currently terminated. Last updated 1 March 2023.

Last reviewed 2023-03-01 · How we verify

NCT04331652: HSC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bipolar 15 Charrières Office Resectoscope : Polypectomy Without Anesthesia

Terminated NA Last updated 1 March 2023

What this trial tests

NA trial testing Polypectomy without anesthesia or analgo-sedation in Polyps Uterus in 13 participants. Terminated before completion.

Timeline

14 December 2020

Primary endpoint
23 May 2022

23 May 2022

Quick facts

Lead sponsor	Hopital Foch
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	13
Start date	14 December 2020
Primary completion	23 May 2022
Estimated completion	23 May 2022
Sites	1 location across France

Drugs / interventions tested

Polypectomy without anesthesia or analgo-sedation

Conditions studied

Polyps Uterus — all drugs for Polyps Uterus →

Sponsor

Hopital Foch — full company profile →

Who can join

18 and older, female only, with Polyps Uterus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to the feasibility of polypectomy without anesthesia using a 15 Ch. resectoscope in women with uterine polyps.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hopital Foch trials

Trials by the same sponsor.

NCT06980844 — Interpretation of the Role of Eosinophils in Diffuse Interstitial Pneumopathies · NA · not yet recruiting
NCT06757244 — DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer · Phase 2 · recruiting
NCT06631794 — Evaluation of the Impact of a HPV Vaccination Talk with Third Grade Students · not yet recruiting
NCT06533436 — Clinical and Economic Comparison of 2 Methods of Intubation Tube Fixation : AnchorFastTM Versus Current Cord Fixation · NA · recruiting
NCT06476002 — Analysis of the Understanding of the French Version of the Vulvar Pain Assessment Questionnaire · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04331652 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hopital Foch
Last refreshed: 1 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04331652.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing